140 related articles for article (PubMed ID: 9147364)
1. Altered expression of various receptors on T cells in young and old mice after mitogenic stimulation: a flow cytometric analysis.
Wakikawa A; Utsuyama M; Hirokawa K
Mech Ageing Dev; 1997 Mar; 94(1-3):113-22. PubMed ID: 9147364
[TBL] [Abstract][Full Text] [Related]
2. CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism.
Toyooka K; Maruo S; Iwahori T; Yamamoto N; Tai XG; Abe R; Takahama Y; Murakami M; Uede T; Hamaoka T; Fujiwara H
Int Immunol; 1996 Feb; 8(2):159-69. PubMed ID: 8671600
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo.
Metzler B; Burkhart C; Wraith DC
Int Immunol; 1999 May; 11(5):667-75. PubMed ID: 10330272
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen.
Ampel NM; Christian L
Med Mycol; 2000 Apr; 38(2):127-32. PubMed ID: 10817229
[TBL] [Abstract][Full Text] [Related]
5. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
Chen W; Jin W; Wahl SM
J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
[TBL] [Abstract][Full Text] [Related]
6. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
7. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
Dahlén E; Hedlund G; Dawe K
J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas TL; Bakker CY; Bluestone JA
J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
[TBL] [Abstract][Full Text] [Related]
9. Expression of both B7-1 and CD28 contributes to the IL-2 responsiveness of CTLL-2 cells.
Belani R; Weiner GJ
Immunology; 1996 Feb; 87(2):271-4. PubMed ID: 8698390
[TBL] [Abstract][Full Text] [Related]
10. Expression of murine IL-2 receptor beta-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor alpha-chain transgenic mice.
Hattori M; Okazaki H; Ishida Y; Onuma M; Kano S; Honjo T; Minato N
J Immunol; 1990 May; 144(10):3809-15. PubMed ID: 2332632
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
Yi LA; Hajialiasgar S; Chuang E
Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
[TBL] [Abstract][Full Text] [Related]
12. Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation molecule (CD)28 but not CD3 receptors on murine thymocytes and spleen cells.
Kuvibidila SR; Porretta C
Br J Nutr; 2003 Jul; 90(1):179-89. PubMed ID: 12844390
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
Krummel MF; Allison JP
J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
[TBL] [Abstract][Full Text] [Related]
14. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis.
Huang D; Giscombe R; Zhou Y; Pirskanen R; Lefvert AK
J Neuroimmunol; 2000 Jun; 105(1):69-77. PubMed ID: 10713366
[TBL] [Abstract][Full Text] [Related]
15. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.
Wang XB; Zheng CY; Giscombe R; Lefvert AK
Scand J Immunol; 2001 Nov; 54(5):453-8. PubMed ID: 11696196
[TBL] [Abstract][Full Text] [Related]
16. The effect of nicotine on murine CD4 T cell responses.
Zhang S; Petro TM
Int J Immunopharmacol; 1996; 18(8-9):467-78. PubMed ID: 9023586
[TBL] [Abstract][Full Text] [Related]
17. Lower percentage of CD8(high+)CD152(+) but not CD8(high+)CD28(+) T lymphocytes in the elderly may be reverted by interleukin 2 in vitro.
Trzonkowski P; Myśliwska J; Szmit E; Zak M; Foerster J; Myśliwski A
Mech Ageing Dev; 2002 May; 123(9):1283-93. PubMed ID: 12020949
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
Lombardi VR; García M; Rey L; Cacabelos R
J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
[TBL] [Abstract][Full Text] [Related]
20. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]